Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pablo Gastaminza

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
Gut|June 22, 2013
Dysregulation of interferon regulatory factors impairs the expression of immunostimulatory molecules in hepatitis C virus genotype 1-infected hepatocytesEsther Larrea, Jose-I Riezu-Boj, Rafael Aldabe, et al.
Plos Pathogens|September 19, 2018
Host phosphatidic acid phosphatase lipin1 is rate limiting for functional hepatitis C virus replicase complex formationLidia Mingorance, Victoria Castro, Ginés Ávila-Pérez, et al.
Journal of Leukocyte Biology|January 20, 2024
SARS-CoV-2 membrane protein-specific antibodies from critically ill SARS-CoV-2-infected individuals interact with Fc receptor-expressing cells but do not neutralize the virusDaniel Fernández-Soto, Paula Bueno, Urtzi Garaigorta, et al.
Structure (London, England : 1993)|June 24, 2025
Rapid hepatitis C virus replication machinery removal after antiviral treatment with DAA monitored by multimodal imagingVictoria Castro, Gema Calvo, Ana J Pérez-Berná, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 9, 2005
Robust hepatitis C virus infection in vitroJin Zhong, Pablo Gastaminza, Guofeng Cheng, et al.
Pharmaceuticals (Basel, Switzerland)|April 30, 2021
Host-Directed FDA-Approved Drugs with Antiviral Activity against SARS-CoV-2 Identified by Hierarchical In Silico/In Vitro Screening MethodsTiziana Ginex, Urtzi Garaigorta, David Ramírez, et al.
Journal of Virology|March 25, 2011
Antiviral stilbene 1,2-diamines prevent initiation of hepatitis C virus RNA replication at the outset of infectionPablo Gastaminza, Suresh M Pitram, Marlene Dreux, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 22, 2008
A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitroGuofeng Cheng, Ana Montero, Pablo Gastaminza, et al.
Journal of Virology|January 8, 2021
COVID-19 vaccine candidates based on modified vaccinia virus Ankara expressing the SARS-CoV-2 spike induce robust T- and B-cell immune responses and full efficacy in miceJuan García-Arriaza, Urtzi Garaigorta, Patricia Pérez, et al.
RSC Medicinal Chemistry|February 10, 2025
Expanding the chemical space for antiviral discovery: the potential of twistenedionesAida Jaafar, Daniel Guerra-González, Ana Pascual, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Gut|June 22, 2013
Dysregulation of interferon regulatory factors impairs the expression of immunostimulatory molecules in hepatitis C virus genotype 1-infected hepatocytesEsther Larrea, Jose-I Riezu-Boj, Rafael Aldabe, et al.
Plos Pathogens|September 19, 2018
Host phosphatidic acid phosphatase lipin1 is rate limiting for functional hepatitis C virus replicase complex formationLidia Mingorance, Victoria Castro, Ginés Ávila-Pérez, et al.
Journal of Leukocyte Biology|January 20, 2024
SARS-CoV-2 membrane protein-specific antibodies from critically ill SARS-CoV-2-infected individuals interact with Fc receptor-expressing cells but do not neutralize the virusDaniel Fernández-Soto, Paula Bueno, Urtzi Garaigorta, et al.
Structure (London, England : 1993)|June 24, 2025
Rapid hepatitis C virus replication machinery removal after antiviral treatment with DAA monitored by multimodal imagingVictoria Castro, Gema Calvo, Ana J Pérez-Berná, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 9, 2005
Robust hepatitis C virus infection in vitroJin Zhong, Pablo Gastaminza, Guofeng Cheng, et al.
Pharmaceuticals (Basel, Switzerland)|April 30, 2021
Host-Directed FDA-Approved Drugs with Antiviral Activity against SARS-CoV-2 Identified by Hierarchical In Silico/In Vitro Screening MethodsTiziana Ginex, Urtzi Garaigorta, David Ramírez, et al.
Journal of Virology|March 25, 2011
Antiviral stilbene 1,2-diamines prevent initiation of hepatitis C virus RNA replication at the outset of infectionPablo Gastaminza, Suresh M Pitram, Marlene Dreux, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 22, 2008
A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitroGuofeng Cheng, Ana Montero, Pablo Gastaminza, et al.
Journal of Virology|January 8, 2021
COVID-19 vaccine candidates based on modified vaccinia virus Ankara expressing the SARS-CoV-2 spike induce robust T- and B-cell immune responses and full efficacy in miceJuan García-Arriaza, Urtzi Garaigorta, Patricia Pérez, et al.
RSC Medicinal Chemistry|February 10, 2025
Expanding the chemical space for antiviral discovery: the potential of twistenedionesAida Jaafar, Daniel Guerra-González, Ana Pascual, et al.
Pageof 5